Ranibizumab or Aflibercept Monotherapies in Treatment-Naive Eyes with Diabetic Macular Edema: A Head-to-Head Comparison in Real-Life Experience

OBJECTIVES: To compare the functional and anatomical outcomes of ranibizumab and aflibercept monotherapies given according to a pro re nata (PRN) protocol in treatment-naive eyes with diabetic macular edema (DME) in a real-life clinical setting. MATERIALS AND METHODS: The medical charts of treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaya, Mahmut, Öztürk, Taylan, Koçak, Nilüfer, Akbulut Yağcı, Betül, Ataş, Ferdane, Kaynak, Süleyman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9973208/
https://www.ncbi.nlm.nih.gov/pubmed/36847631
http://dx.doi.org/10.4274/tjo.galenos.2022.38227

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9973208/
https://www.ncbi.nlm.nih.gov/pubmed/36847631
http://dx.doi.org/10.4274/tjo.galenos.2022.38227

Ejemplares similares